Company intelligence / Profile preview
Crystal Genomics
Seongnam-si, Gyeonggi-do, South Koreacrystalgenomics.com ↗
- Ownership
- Public · 083790
- Development stage
- Other
01
Overview
Crystal Genomics has a commercial product Acelex (polmacoxib) for osteoarthritis, which is approved and marketed in Korea and exported globally[2][3]. The pipeline features first-in-class and best-in-class candidates in anti-infectives (CG-549, Phase 1), oncology (ivaltinostat, CG-806, Phase 1/2), pain, inflammation, and fibrosis at various stages, including several orphan drug designations in Korea and the US[2][3][5].
- Therapeutic areas
- RheumatologyGastroenterologyInfectious DiseasesNeurologyOtherOncology
- Modalities
- Small moleculeProtein
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Dong-A ST (commercialization of Acelex in Korea)TR-Pharm (Turkey & MENA)Aspen Pharma (Brazil)PharmArtis International (Russia)Aptose Biosciences (co-development and global rights for CG-806)Jiangsu Hengrui (immuno-oncology in-license for Korea)Bellevue Asset Management (strategic partnership)
Beyond the preview
Go deeper on Crystal Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crystal Genomics.